Case Report

Necrotizing Lymphadenitis Associated with the Phenytoin-induced Hypersensitivity Syndrome

Authors: Karthi Subbannan, MD, Jaspal S. Gujral, MBBS, FACP, MRCP

Abstract

A 32-year-old black female was started on phenytoin for seizure prophylaxis following the clipping of an aneurysm. This was stopped after 3 weeks when she developed a generalized skin rash. Over the next week she developed fever, sore throat, dysphagia, and headache. She had an erythematous throat with white exudates on the right tonsil and 1 to 3 cm firm, tender lymphadenopathy in multiple regions. Blood, throat swab and cerebrospinal fluid studies were negative for bacterial or viral infections, except for elevated liver enzymes. CT scan of chest, abdomen, and pelvis showed no lymphadenopathy. Lymph node biopsy suggested necrosis but no evidence of infection, granuloma, or lymphoma. Her lymphadenopathy resolved spontaneously and liver enzymes normalized in 3 weeks. Hypersensitivity syndrome due to antiepileptics manifests as fever, rash, generalized lymphadenopathy, and probably represents a T-cell mediated drug reaction. This reaction may persist despite cessation of the drug, and it may engender expensive evaluation. Careful observation up to 3 weeks after drug cessation may be the best management.


Key Points


* Phenytoin and other anticonvulsants can cause generalized lymphadenopathy and necrotizing lymphadenitis as part of hypersensitivity syndrome.


* It is probably T-cell mediated reaction and extensive workup is not required.


* It is usually self-limiting when the offending drug is stopped but can be fatal with liver involvement.


* Genetic factors contribute and first-degree relatives should be counseled to avoid phenytoin and related anticonvulsants.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Kruspe R, Broussard A, Santanilla J, et al. Journal of the Louisiana state medical society Lymphoma or pseudolymphoma? 2002;154:178–182.
 
2. Romero K, Maldonado N, Sendra Tello J, et al. Eur J Dermatology Anticonvulsant hypersensitivity syndrome with fatal outcome. 2002;12:503–505.
 
3. Kaur S, Sarkar R, Thami GP, et al. Pediatric Dermatology Anticonvulsant hypersensitivity syndrome. 2002;19:142–145.
 
4. Schaub KN, Bircher AJ. Severe hypersensitivity syndrome to lamotrigine confirmed by lymphocyte stimulation in vitro. Allergy 2000;55:191.
 
5. Kennebeck GA. Anticonvulsant hypersensitivity syndrome. J Am Board Fam Pract 2000;13:364–370.
 
6. Bessmertny O, Hatton RC, Gonzalez-Peralta RP. Antiepileptic hypersensitivity syndrome in childrenAnn Pharmacother 2001;35:533–53.
 
7. Vittorio CC, Muglia JJ. Anticonvulsant hypersensitivity syndrome. Arch Intern Med 1995;55: 2285–2290.
 
8. Mahadeva M, Al-Mrayat Ksteer, Steer K, et al. Fatal phenytoin hypersensitivity syndrome. Postgrad Med J 1999;75:734–737.